The Oklahoman (8/26, Colberg) reports that "17 mainstay drugs used in chemotherapy are currently in short supply." In the August issue of the American Society of Clinical Oncology Post, Dr. Derek Raghavan argues that "the shortage of cytotoxic drugs...will certainly lead to an epidemic of avoidable deaths." Other safety issues have arisen. For instance, "two deaths in patients related to an accidental overdose of a pain medication substituted" for morphine, and blood infections that resulted from "contamination of a substituted powder form of a nutritional solution commonly used by cancer patients."